Additionally, SCLC–YAP1 is validated to be enriched in T cell infiltration, whereas SCLC–ASCL1 and SCLC–NEUROD1 show less immune inflammation and T cell dysfunction.191, 192, 193. Here, ASCL1 is linked to small cell lung carcinoma.